• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER Back to Search Results
Model Number G8
Device Problem Device Operational Issue (2914)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/28/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).A 13 month complaint history review and service history review for similar complaints was performed for serial number (b)(4) from 28-feb-2017 through aware date 28-mar-2018 there were no similar complaints identified during the searched period.The g8 operator's manual under chapter 1 - introduction and applications, states the following: the time from injection of the sample to the time the specific peak elutes off the column is called retention time.The tosoh automated glycohemoglobin analyzer hlc-723g8 software has been written so that each of the expected fractions has a window of acceptable retention times.If the designated peak falls within the expected window, the chromatogram peaks will be properly identified.When a peak elutes at a retention time not within a specified window, an unknown peak (p00) results.If more than one peak elutes at times not specified by the software windows, each is given a sequential p0x title.In order to keep the peaks within their appropriate windows, it may be necessary to change how fast or slow the buffers are moving through the system by changing the pump flow rate.In chapter 5- maintenance procedures, under daily checklist states: be sure to check the following items before starting analysis: (1) column, the maintenance schedule is 2500 tests; (2) filter, maintenance schedule if 400 tests.The g8 variant analysis mode training manual under lesson 8 - troubleshooting, states the following: adjusting the flow rate - how and why on the tosoh automated glycohemoglobin analyzer hlc-723g8; variant analysis mode it may be necessary to adjust the flow rate because either unidentifiable peaks appear on all the chromatograms or the average retention time for various peaks has changed significantly.The flow rate is changed by changing the flow factor in the instrument.The flow factor is generally 1.00 ml/min.The flow factor should only be adjusted +/- 0.05 of the default factory setting.The most probable cause of the reported event was due to the flow factor adjustment.
 
Event Description
On (b)(6) 2018, a customer reported getting fast retention time (rt) of 0.62 minute (the acceptable range is 0.57 to 0.61 minutes; optimal is 0.59 minute) on the g8 instrument.Customer requested help with flow factor adjustment.Customer noted the column count is 1271 (recommended changing the column at 2500 injections).Technical support specialist (tss) provided instruction to the customer on how to adjust the flow factor from 1.00 to 1.03.Customer stated does not plan to run patient samples or quality controls (qc) at this time to check for the retention time.Customer stated the instruction provided by technical support specialist (tss) will be used to make any further adjustments should they be required by the customer.Tss advised the customer that calibration will be required after the adjustment.It is not known whether hemoglobin a1c results were different before and after the retention time adjustment.There is no indication of any patient intervention or adverse health consequences due to this event.
 
Manufacturer Narrative
H.11 corrected data in the previous mdr reported, section b.3 date of event was(b)(6)2018.The corrected date is(b)(6)2018.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 10586 23
JA  1058623
MDR Report Key7453326
MDR Text Key106270033
Report Number8031673-2018-00348
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
PMA/PMN Number
K071132
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 07/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA07/30/2018
Distributor Facility Aware Date07/14/2018
Device Age8 YR
Event Location Outpatient Diagnostic Facility
Date Report to Manufacturer07/30/2018
Date Manufacturer Received03/28/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-